Condition: Stroke · Acute Stroke · Ischemic Stroke · Sponsor: Tatchempharmpreparaty, JSC
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dimephosphon® in acute ischemic stroke
This description comes directly from the study's public registry record.
Alfiya Fakhrieva · +78435269764 · iksanova@tatpharm.ru
Alyona Tirskaya · +7812309847 · atirskaya@x7research.ru
Always discuss trial participation with your own doctor first.
| State Budgetary Healthcare Institution of the Leningrad Region "Vsevolozhsk Interdistrict Clinical Hospital | Vsevolozhsk, Leningradskaya Oblast', Russia | Recruiting |
| State Budgetary Healthcare Institution "Research Institute - Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky" of the Ministry of Health of the Krasnodar region | Krasnodar, Russia | Not Yet Recruiting |
| Federal State Autonomous Educational Institution of Higher Education "Peoples' Friendship University of Russia named after Patrice Lumumba" | Moscow, Russia | Recruiting |
| The FSBI "Federal Center of Brain Research and Neurotechnologies" of the Federal Medical and Biological Agency | Moscow, Russia | Recruiting |
| Saint Petersburg State Budgetary Healthcare Institution "City Hospital No. 40 of the Kurortny District" | Saint Petersburg, Russia | Recruiting |
| State Budgetary Healthcare Institution "City Hospital No. 4 of Sochi" of the Ministry of Healthcare of the Krasnodar Region | Sochi, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07167550